LMR by IFF Inaugurates New Experimental Field in Grasse

28.5.2026 12:00:00 EEST | Business Wire | Press release

LMR Naturals by IFF—a global leader in natural ingredients for perfumery, cosmetics and flavors—today inaugurated its new experimental field, Domaine des Naturels LMR. The field is dedicated to advancing research in natural ingredients, preserving Grasse’s agricultural heritage and expanding education in naturals. The inauguration, attended by Grasse Mayor Jérôme Viaud, a long-standing supporter of the perfume industry, underscores IFF and LMR’s ongoing commitment to the region.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260527694524/en/

At Domaine des Naturels LMR, R&D experts research new natural species, variety breeding, cultivation methods and production techniques.

“This inauguration reflects over two decades of continuous investment in Grasse and in naturals,” said Ana Paula Mendonça, president, Scent, IFF. “With Domaine des Naturels LMR, we are bringing together innovation, preservation and knowledge sharing to shape the next chapter of natural ingredients, powered by deep scientific expertise and a truly global innovation network. What matters most is what this unlocks for our customers: more creative freedom, more distinctive ingredients, and ultimately true differentiation.”

Driving sustainable innovation in naturals
The 1.8-hectare experimental field operates as an integrated research and development platform. Located near LMR’s Grasse headquarters and its high-end creation site, L’Atelier du Parfumeur, Domaine des Naturels LMR enables a seamless approach from seed to fragrance.

Sabrya Meflah, president of fine fragrance, Scent, IFF, said, “The Domaine des Naturels LMR is a fantastic creative playground for our artists of perfumery to find inspiration and invent the signatures of tomorrow, building on our unique Grasse and global innovation ecosystem.”

Acquired by IFF in 2025, the field builds on the legacy of pioneering farmer Constant Viale, its former owner. Domaine des Naturels LMR maintains a collection of endemic species, including rose, jasmine, tuberose, iris, narcissus and olive trees. Combining traditional cultivation methods with advanced agronomic approaches, LMR continues to protect and develop Grasse’s distinctive know-how. Terraced farming, organic practices and biodiversity initiatives help preserve both the landscape and its ecological balance.

The experimental field allows local teams to explore plant varieties, refine cultivation techniques and assess bio-based inputs under real-world conditions.By integrating agronomy, extraction and perfumery—supported by a multidisciplinary team of more than 10 botanical experts—LMR enhances its ability to design, validate and scale distinctive natural raw materials while supporting more resilient agricultural systems. With a comprehensive approach to sustainability, the field includes diversified water sourcing, support for pollinators and the development of habitats for local wildlife, further strengthening LMR’s long-standing commitment to environmental stewardship.

Stewardship and education
Domaine des Naturels LMR also serves as an immersive environment dedicated to natural ingredients education, offering customers, partners and perfumers direct insight into the realities of sourcing and cultivating natural materials.

The site will gradually host the LMR Naturals Academy, with training programs and hands-on experiences to deepen expertise and ensure the transmission of this specialized knowledge.

“By bringing together innovation, heritage and education, LMR Naturals by IFF continues to shape what comes next for naturals,” said Bertrand de Préville, general manager of LMR Naturals by IFF. “We’re anchored in Grasse, connected to a global network and driven by a long-term vision.”

Since acquiring LMR Naturals in 2000, IFF has steadily invested in Grasse. Building on the pioneering vision of LMR founder Monique Rémy, this sustained commitment continues to elevate standards in natural ingredients by blending science, agriculture and the art of perfumery. It also anchors Grasse within a global research network spanning Brazil, the United States, Asia and beyond, enabling knowledge generated at Domaine des Naturels LMR to extend across IFF’s 14 innovation platforms worldwide.

About LMR Naturals by IFF
Founded in 1983 by Monique Rémy and acquired by IFF in 2000, LMR Naturals is a trademarked capability within IFF dedicated to the development of high‑quality, innovative and sustainably sourced natural ingredients. LMR Naturals supports perfumers worldwide with a broad portfolio of naturals across fine fragrance, beauty, personal care, home care and flavorists with taste applications. For more information, visit https://www.iff.com/scent/lmr-naturals/.

Welcome to IFF
At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the global leader in taste, scent, food ingredients, health and biosciences, we’re innovating for the future. Every day, we deliver groundbreaking, sustainable solutions that elevate products people love—advancing wellness, delighting the senses and enhancing the human experience. Learn more at iff.com, LinkedIn, Instagram and Facebook.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260527694524/en/

Contacts

Judith Gross, VP, Communications & Branding
Department: Scent
Email: scentmediarequest@iff.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Amadeus Redefines Travel Advertising to Help Brands Capture Demand Earlier28.5.2026 14:00:00 EEST | Press release

Amadeus today introduced the Amadeus Travel Advertising Platform at its Advertising Summit in Nice, France. Leveraging Accenture’s agentic framework for campaign execution, the platform outlines a new approach designed to help travel companies make faster, smarter advertising decisions based on where demand is forming — not just where it has already converted. Travel advertising has become increasingly complex, fragmented across channels and often driven by historical performance signals that arrive too late to capture emerging demand. As travelers plan trips across AI chatbots, search, social, metasearch, content platforms and OTAs long before booking, travel brands face rising acquisition costs and growing pressure to prove return on investment. The Amadeus Travel Advertising Platform connects forward-looking travel demand intelligence with advertising planning, activation and AI-supported decision-making. This enables travel brands to drive profitable demand and decisions by investi

Kinaxis Convenes Global Supply Chain Leaders at Kinexions North America to Advance Agentic AI and Decision Orchestration28.5.2026 14:00:00 EEST | Press release

Kinaxis® (TSX:KXS), a global leader in end-to-end supply chain planning and orchestration, is set to host Kinexions North America kicking off next week from June 1-3 at The Cosmopolitan of Las Vegas. The company’s flagship conference will bring together global supply chain, business and technology leaders for three days of product innovation, customer insights, and peer networking as Kinaxis continues to advance its focus on AI-driven decision making across the supply chain industry. This year’s event will spotlight how organizations are applying agentic AI and orchestration, moving beyond insight to execution, and increasingly from decisions to coordinated action. Speakers from global organizations including Merck, Bristol Myers Squibb, Unilever, British American Tobacco, Qualcomm, ExxonMobil, The Hershey Company, Scotts Miracle-Gro, and Veolia,will join Kinaxis executives to share how they are navigating disruption and improving operational outcomes. Kinaxis CEO, Razat Gaurav is set

Compass Pathways Elects Kathleen Tregoning to Board of Directors28.5.2026 13:30:00 EEST | Press release

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the election of Kathleen Tregoning to its Board of Directors at the annual general meeting of shareholders. Ms. Tregoning is expected to serve on the Compensation and Leadership Development Committee and the Nominating and Corporate Governance Committee. She brings extensive experience guiding biopharmaceutical companies through periods of growth and transformation, with expertise spanning corporate strategy, external affairs, public policy and patient access. “With two successful Phase 3 trials meeting the primary endpoint, a transformative clinical profile for COMP360, and a rolling NDA submission and review now underway, Compass is strongly positioned to make our goal of securing an FDA approval a reality. Compass is entering a stage where experience in external engagement, public policy, and patient access matters more

Alzprotect Announces FDA Clearance of IND for AZP2006 (Ezeprogind®) in Progressive Supranuclear Palsy (PSP)28.5.2026 13:28:00 EEST | Press release

Alzprotect today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND) application for AZP2006 (Ezeprogind®) for the treatment of Progressive Supranuclear Palsy (PSP). FDA clearance permits the Company to begin clinical development of AZP2006 in the United States. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260526387210/en/ “FDA IND clearance is a pivotal step in our PSP program,” said Philippe Verwaerde, PhD, President & Chief science Officer. “We can now expand our clinical efforts in the U.S. to evaluate AZP2006’s potential to address PSP, a severe neurodegenerative disease with no approved disease-modifying therapies.” Dr. Artin Karapet, Chief Medical Officer, commented: “The FDA’s clearance of our IND for AZP2006 is a pivotal milestone, aligning U.S. and European regulatory pathways and enabling the initiation of rigorous clinical trials in the United Stat

Reply Expands Prebuilt AI Apps With New Production-Ready Applications to Accelerate Enterprise AI Adoption28.5.2026 11:00:00 EEST | Press release

Reply[EXM, STAR: REY] today released a new set of Prebuilt AI Apps: ready-to-use agentic applications designed to drive efficiency and business growth by accelerating the integration of AI into enterprise processes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260528283268/en/ Prebuilt AI Apps are ready-to-use agentic applications designed to accelerate the integration of AI into enterprise processes, driving efficiency and supporting business growth. In developing the Prebuilt AI Apps, Reply has identified key areas within enterprise processes where AI can create tangible operational value and turned them intoreusable assets, combining deep process knowledge, curated datasets, domain ontologies and reusable agentic flows in robust, secure and production-ready solutions. Each application can be further customised and extended through integration with enterprise systems, internal data and knowledge bases, while maintaining

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom